IDiyas

For the Inventor, By the Inventor

Hyderabad Telangana, India

Uma Maheswar Rao Vasireddi

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 6.6

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:

goldMedal9 out of 64 
 
Laurus Labs Private Limited
 patents

Years Active: 2019-2024

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents
1. 12071418 - Processes for preparation of dapagliflozin or its solvates or co-crystals thereof (2024-08-27),
2. 11427555 - Processes for preparation of dapagliflozin or its solvates or co-crystals thereof (2022-08-30),
3. 11318116 - Stable amorphous form of sacubitril valsartan trisodium complex and processes for preparation thereof (2022-05-03),
4. 11046676 - Process for preparation of empagliflozin or its co-crystals, solvates and their polymorphs thereof (2021-06-29),
5. 11040961 - Co-crystals of SGLT2 inhibitors, process for their preparation and pharmaceutical compositions thereof (2021-06-22),
6. 10857132 - Stable amorphous form of sacubitril valsartan trisodium complex and processes for preparation thereof (2020-12-08),
7. 10836753 - Co-crystals of SGLT2 inhibitors, process for their preparation and pharmaceutical compositions thereof (2020-11-17),
8. 10738038 - Co-crystals of SGLT2 inhibitors, process for their preparation and pharmaceutical compositions thereof (2020-08-11),
9. 10428053 - Co-crystals of SGLT2 inhibitors, process for their preparation and pharmaceutical compositions thereof (2019-10-01),

Title: Innovations of Uma Maheswar Rao Vasireddi

Introduction

Uma Maheswar Rao Vasireddi is a prominent inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for the preparation of important medications. With a total of nine patents to his name, he has established himself as a key figure in innovation.

Latest Patents

His latest patents focus on the processes for the preparation of dapagliflozin or its solvates or co-crystals. Dapagliflozin is an inhibitor of sodium-dependent glucose transporters and is primarily used for treating diabetes. The inventions encompass improved processes for the preparation of dapagliflozin, including novel intermediates and their applications in the synthesis of this important drug.

Career Highlights

Uma Maheswar Rao Vasireddi is currently associated with Laurus Labs Private Limited, where he continues to drive innovation in pharmaceutical processes. His work has not only contributed to the advancement of diabetes treatment but has also paved the way for further research in the field.

Collaborations

He has collaborated with notable coworkers such as Ram Thaimattam and Sivarami Reddy Yasam, contributing to a dynamic and innovative work environment.

Conclusion

Uma Maheswar Rao Vasireddi's contributions to the pharmaceutical industry through his patents and innovative processes highlight his importance as an inventor. His work continues to impact the treatment of diabetes and showcases the potential of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…